8-K - Acurx Pharmaceuticals, Inc. (0001736243) (Filer)
Published . Updated .
Filed: 2026-10-16 AccNo: 0001104659-26-116632 Size: 194 KB Item 5.07: Submission of Matters to a Vote of Security Holders
Directly affected
- ACXP Acurx Pharmaceuticals
Named in this report.
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
Filed: 2026-10-16 AccNo: 0001104659-26-116632 Size: 194 KB Item 5.07: Submission of Matters to a Vote of Security Holders
Source: sec-edgar
Acurx Pharmaceuticals (ACXP) since this story, compared with the market
| Company | When | Move | Status |
|---|---|---|---|
| Acurx Pharmaceuticals (ACXP) | that day | +3.64% | final price |
| Acurx Pharmaceuticals (ACXP) | the next day | +1.83% | still updating |
| Acurx Pharmaceuticals (ACXP) | three days earlier | +10.50% | final price |
| Acurx Pharmaceuticals (ACXP) | five days earlier | +15.53% | final price |
| GLD | that day | -0.63% | final price |
| GLD | the next day | -0.98% | still updating |
| GLD | three days earlier | -1.59% | final price |
| GLD | five days earlier | +0.03% | final price |
| QQQ | that day | +1.20% | final price |
| QQQ | the next day | +0.87% | still updating |
| QQQ | three days earlier | +2.70% | final price |
| QQQ | five days earlier | +5.10% | final price |
| SPY | that day | +0.43% | final price |
| SPY | the next day | +0.61% | still updating |
| SPY | three days earlier | +0.83% | final price |
| SPY | five days earlier | +1.93% | final price |
| TLT | that day | -0.72% | final price |
| TLT | the next day | +0.10% | still updating |
| TLT | three days earlier | -1.44% | final price |
| TLT | five days earlier | -2.51% | final price |
Who gains and who loses around Acurx Pharmaceuticals (ACXP)
Companies tied to this story
- ACXP Acurx Pharmaceuticals
Acurx Pharmaceuticals (ACXP) is linked, with no stored direction, high confidence in the 16 Oct 2026 story “8-K - Acurx Pharmaceuticals, Inc. (0001736243) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> ACXP
How “8-K - Acurx Pharmaceuticals, Inc. (0001736243) (Filer)” reaches Acurx Pharmaceuticals (ACXP)
The 16 Oct 2026 story “8-K - Acurx Pharmaceuticals, Inc. (0001736243) (Filer)” names Acurx Pharmaceuticals (ACXP) because of this story.
For Acurx Pharmaceuticals (ACXP), the reason on file says SEC 8-K filing -> direct issuer disclosure -> ACXP
Dates in the story, and the Acurx Pharmaceuticals (ACXP) price range
ACXP traded between 1.07 and 1.45 across 11 sessions. The latest close on file is 1.13.
A simple score for Acurx Pharmaceuticals (ACXP)
20 out of 100Price not final
“8-K - Acurx Pharmaceuticals, Inc. (0001736243) (Filer)” scores 20 out of 100. The score uses 1 sources, a +1.22% difference versus the S&P 500 (SPY), and 1 linked companies. The price is not final yet.